R. Bumm

Risk factors for surgical treatment in the Dutch gastric cancer trial

Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases

GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH COLUMNAR-LINED ESOPHAGUS

ESPEN guideline: Clinical nutrition in surgery

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation

Esophageal Cancer

Thoracic Multidisciplinary Tumor Board Routinely Impacts Therapeutic Plans in Patients With Lung and Esophageal Cancer: A Prospective Cohort Study

Extended Lymph-Node Dissection for Gastric Cancer

Curative Resection for Esophageal Adenocarcinoma

Oesophageal carcinoma

Oximes in organophosphate poisoning: 60 years of hope and despair

Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: A kinetic analysis

Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure

Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

The immune contexture in human tumours: impact on clinical outcome

Gastric cancer

The value of novel oximes for treatment of poisoning by organophosphorus compounds

Skeletonizing En Bloc Esophagectomy for Cancer

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Relationship of Gastroesophageal Reflux Disease with Adenocarcinoma of the Distal Esophagus and Cardia

Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro

Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase

Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction

Early adenocarcinoma in Barrett's oesophagus

In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species

Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus

Lymphocyte subsets and T h 1/T h 2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome

Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer

Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity

Endodissection of the Thoracic Esophagus Technique and Clinical Results in Transhiatal Esophagectomy

Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6

Prognostic factors of resected adenocarcinoma of the esophagus

Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors

Interaction of gastroesophageal reflux and esophageal motility

Radical Transhiatal Esophagectomy with Two‐Field Lymphadenectomy and Endodissection for Distal Esophageal Adenocarcinoma

Impact of multidisciplinary tumor boards on diagnosis and treatment of esophageal cancer